Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 77 out of 100. Biomarkers

Topic: Plasma and spinal-fluid biomarkers

Plain-language summary

A total of 17 articles were identified. Plasma Aβ42/40 ratio was inversely correlated with aPET positivity r = -0.48 (95% confidence interval (CI): -0.65--0.31). In numerous studies, plasma Aβ42/40 ratio was also found to be directly correlated with CSF Aβ42 and CSF Aβ42/40 ratio r = 0.50 (95% CI: 0.30-0.69). Three studies found plasma Aβ42 to be positively associated with aPET positivity and CSF Aβ42; however, four other studies found no significant association between these variables. Seven studies reported no significant association of plasma Aβ40 with aPET or CSF Aβ40. Plasma Aβ42/40 ratio seems as a promising plasma biomarker as it significantly correlates inversely with aPET positivity and directly with CSF Aβ42 and CSF Aβ42/40 ratio. However, more research is warranted, including validation studies, longitudinally clinical studies, studies comparing measurement methods and studies of Aβ kinetics.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Ebbesen, S. U., Høgh, P., & Zibrandtsen, I. (2023). Plasma Aβ biomarker for early diagnosis and prognosis of Alzheimer's disease - a systematic review. Danish medical journal.

Vancouver

Ebbesen SU, Høgh P, Zibrandtsen I. Plasma Aβ biomarker for early diagnosis and prognosis of Alzheimer's disease - a systematic review. Danish medical journal. 2023. PMID: 37341353.

BibTeX

@article{ebbesen2023-37341353,
  author  = {Ebbesen, Svend Ubbe and Høgh, Peter and Zibrandtsen, Ivan},
  title   = {{Plasma Aβ biomarker for early diagnosis and prognosis of Alzheimer's disease - a systematic review}},
  journal = {Danish medical journal},
  year    = {2023},
  pmid    = {37341353}
}

Built from the record alzhub holds for this paper, not looked up. This record has no DOI, so the citation leaves it out. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Study details

How this study scored 77/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read left out, no data. 43 of the 56 points it could be judged on, which is 77 of 100. Total 77 of 100.43 of the 56 points we could judge = 77 of 100

Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for effect reported because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 43 of the 56 points we could judge it on, which is 77 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Danish medical journal)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 12 / 12 A systematic review of all the studies on the question
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 1 / 4 17 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 37341353)
Free to read — / 2 Access not recorded — left out of this score
Points 43 / 56 Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 43 of the 56 points we could judge it on is 77 out of 100.
Total 77 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Biomarkers from nearby years

Also tagged “p-tau217”

692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Biomarkers

See all studies in Biomarkers →